Fengyuan Lu
Papers
1
Total Citations
8
H-Index
1
About
Fengyuan Lu is a surgical oncologist whose research focuses on advancing minimally invasive pancreatic surgery, particularly through comparative analyses of robotic and laparoscopic techniques. His most-cited work, a 2019 retrospective single-center study on distal pancreatectomy, provides critical insights into the trade-offs between these approaches. Lu demonstrates that both robotic distal pancreatectomy (RDP) and laparoscopic distal pancreatectomy (LDP) are safe and feasible, but RDP offers distinct advantages—namely, significantly less intraoperative blood loss and a higher spleen-preserving rate. However, he also notes the higher cost of RDP, positioning it as especially suitable for non-malignant diseases of the pancreatic body and tail where splenic preservation is prioritized. This balanced, evidence-based contribution has garnered 8 citations, reflecting its practical value for surgeons weighing operative options. Lu’s work directly informs clinical decision-making, helping to tailor surgical approaches to patient pathology and resource considerations. His research underscores a commitment to optimizing outcomes through rigorous comparison of emerging technologies, making him a thoughtful voice in the evolution of pancreatic surgery.
Research Focus
Key Achievements
Top Papers
- 1